Buspirone Hydrochloride Tablet
FDA Label NDC 65841-784

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Buspirone Hydrochloride (NDC 65841-784). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-781-01 in bottle of 100 tablets

Buspirone Hydrochloride Tablets USP, 5 mg

R_x only

100 tablets

Buspirone Hydrochloride Tablets Usp, 5 mg (A12103d4 9e45 4a9c A8c2 3a08fd71b043 04)

NDC 65841-782-01 in bottle of 100 tablets

Buspirone Hydrochloride Tablets USP, 10 mg

R_x only

100 tablets

Buspirone Hydrochloride Tablets Usp, 10 mg (A12103d4 9e45 4a9c A8c2 3a08fd71b043 05)

NDC 65841-783-01 in bottle of 100 tablets

Buspirone Hydrochloride Tablets USP, 15 mg

R_x only

100 tablets

Buspirone Hydrochloride Tablets Usp, 15 mg (A12103d4 9e45 4a9c A8c2 3a08fd71b043 06)

NDC 65841-784-14 in bottle of 60 tablets

Buspirone Hydrochloride Tablets USP, 30 mg

R_x only

60 tablets

Buspirone Hydrochloride Tablets Usp, 30 mg (A12103d4 9e45 4a9c A8c2 3a08fd71b043 07)

* Please review the disclaimer below.